Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-058431
Filing Date
2011-12-02
Accepted
2011-12-02 15:54:51
Documents
1
Period of Report
2011-12-01

Document Format Files

Seq Description Document Type Size
1 12-1 FORM 4 rrd327009.html 4  
1 12-1 FORM 4 rrd327009.xml 4 3595
  Complete submission text file 0001181431-11-058431.txt   4962
Mailing Address ALLOS THERAPEUTICS, INC. 11080 CIRCLEPOINT ROAD, SUITE 200 WESTMINSTER CO 80020
Business Address
EDWARDS MARK G (Reporting) CIK: 0001190429 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 111240382

Mailing Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations